181 related articles for article (PubMed ID: 18567002)
1. Prostate-derived Ets transcription factor as a favorable prognostic marker in ovarian cancer patients.
Ghadersohi A; Odunsi K; Zhang S; Azrak RG; Bundy BN; Manjili MH; Li F
Int J Cancer; 2008 Sep; 123(6):1376-84. PubMed ID: 18567002
[TBL] [Abstract][Full Text] [Related]
2. Prostate-derived Ets transcription factor (PDEF) is a potential prognostic marker in patients with prostate cancer.
Ghadersohi A; Sharma S; Zhang S; Azrak RG; Wilding GE; Manjili MH; Li F
Prostate; 2011 Aug; 71(11):1178-88. PubMed ID: 21656828
[TBL] [Abstract][Full Text] [Related]
3. Prostate-derived Ets transcription factor (PDEF) downregulates survivin expression and inhibits breast cancer cell growth in vitro and xenograft tumor formation in vivo.
Ghadersohi A; Pan D; Fayazi Z; Hicks DG; Winston JS; Li F
Breast Cancer Res Treat; 2007 Mar; 102(1):19-30. PubMed ID: 16897429
[TBL] [Abstract][Full Text] [Related]
4. Prostate-derived Ets transcription factor overexpression is associated with nodal metastasis and hormone receptor positivity in invasive breast cancer.
Turcotte S; Forget MA; Beauseigle D; Nassif E; Lapointe R
Neoplasia; 2007 Oct; 9(10):788-96. PubMed ID: 17971898
[TBL] [Abstract][Full Text] [Related]
5. Prostate-derived Ets factor is overexpressed in serous epithelial ovarian tumors.
Rodabaugh KJ; Mhawech-Fauceglia P; Groth J; Lele S; Sood AK
Int J Gynecol Pathol; 2007 Jan; 26(1):10-5. PubMed ID: 17197890
[TBL] [Abstract][Full Text] [Related]
6. Prostate derived Ets transcription factor shows better tumor-association than other cancer-associated molecules.
Ghadersohi A; Odunsi K; Lele S; Collins Y; Greco WR; Winston J; Liang P; Sood AK
Oncol Rep; 2004 Feb; 11(2):453-8. PubMed ID: 14719083
[TBL] [Abstract][Full Text] [Related]
7. Loss of PDEF, a prostate-derived Ets factor is associated with aggressive phenotype of prostate cancer: regulation of MMP 9 by PDEF.
Johnson TR; Koul S; Kumar B; Khandrika L; Venezia S; Maroni PD; Meacham RB; Koul HK
Mol Cancer; 2010 Jun; 9():148. PubMed ID: 20550708
[TBL] [Abstract][Full Text] [Related]
8. HOXB13 regulates the prostate-derived Ets factor: implications for prostate cancer cell invasion.
Kim IJ; Kang TW; Jeong T; Kim YR; Jung C
Int J Oncol; 2014 Aug; 45(2):869-76. PubMed ID: 24898171
[TBL] [Abstract][Full Text] [Related]
9. Analysis of select members of the E26 (ETS) transcription factors family in colorectal cancer.
Deves C; Renck D; Garicochea B; da Silva VD; Giulianni Lopes T; Fillman H; Fillman L; Lunardini S; Basso LA; Santos DS; Batista EL
Virchows Arch; 2011 Apr; 458(4):421-30. PubMed ID: 21318373
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of PDEF factor expression and its relation to androgen receptor in ER
Cao L; Li C; Xu C; Xiang G; Liu F; Liu X; Jiao J; Lv S; Niu Y
Histopathology; 2018 Nov; 73(5):819-831. PubMed ID: 29969155
[TBL] [Abstract][Full Text] [Related]
11. Prostate-derived Ets factor, an oncogenic driver in breast cancer.
Sood AK; Geradts J; Young J
Tumour Biol; 2017 May; 39(5):1010428317691688. PubMed ID: 28468594
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms and functional consequences of PDEF protein expression loss during prostate cancer progression.
Turner DP; Findlay VJ; Moussa O; Semenchenko VI; Watson PM; LaRue AC; Desouki MM; Fraig M; Watson DK
Prostate; 2011 Dec; 71(16):1723-35. PubMed ID: 21446014
[TBL] [Abstract][Full Text] [Related]
13. IMP3 expression in human ovarian cancer is associated with improved survival.
Noske A; Faggad A; Wirtz R; Darb-Esfahani S; Sehouli J; Sinn B; Nielsen FC; Weichert W; Buckendahl AC; Röske A; Müller B; Dietel M; Denkert C
Int J Gynecol Pathol; 2009 May; 28(3):203-10. PubMed ID: 19620937
[TBL] [Abstract][Full Text] [Related]
14. Prostate derived Ets transcription factor and Carcinoembryonic antigen related cell adhesion molecule 6 constitute a highly active oncogenic axis in breast cancer.
Mukhopadhyay A; Khoury T; Stein L; Shrikant P; Sood AK
Oncotarget; 2013 Apr; 4(4):610-21. PubMed ID: 23592399
[TBL] [Abstract][Full Text] [Related]
15. Induction of apoptosis in human ovarian epithelial cancer cells by antisurvivin oligonucleotides.
Ma X; Wang S; Zhou J; Xing H; Xu G; Wang B; Chen G; Lu YP; Ma D
Oncol Rep; 2005 Jul; 14(1):275-9. PubMed ID: 15944801
[TBL] [Abstract][Full Text] [Related]
16. Ets-1 mRNA expression in effusions of serous ovarian carcinoma patients is a marker of poor outcome.
Davidson B; Risberg B; Goldberg I; Nesland JM; Berner A; Tropé CG; Kristensen GB; Bryne M; Reich R
Am J Surg Pathol; 2001 Dec; 25(12):1493-500. PubMed ID: 11717538
[TBL] [Abstract][Full Text] [Related]
17. AR-PDEF pathway promotes tumour proliferation and upregulates MYC-mediated gene transcription by promoting MAD1 degradation in ER-negative breast cancer.
Cao L; Xu C; Xiang G; Liu F; Liu X; Li C; Liu J; Meng Q; Jiao J; Niu Y
Mol Cancer; 2018 Sep; 17(1):136. PubMed ID: 30217192
[TBL] [Abstract][Full Text] [Related]
18. Expression characteristics of prostate-derived Ets factor support a role in breast and prostate cancer progression.
Sood AK; Saxena R; Groth J; Desouki MM; Cheewakriangkrai C; Rodabaugh KJ; Kasyapa CS; Geradts J
Hum Pathol; 2007 Nov; 38(11):1628-38. PubMed ID: 17521701
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of PLK1 is associated with poor survival by inhibiting apoptosis via enhancement of survivin level in esophageal squamous cell carcinoma.
Feng YB; Lin DC; Shi ZZ; Wang XC; Shen XM; Zhang Y; Du XL; Luo ML; Xu X; Han YL; Cai Y; Zhang ZQ; Zhan QM; Wang MR
Int J Cancer; 2009 Feb; 124(3):578-88. PubMed ID: 19004025
[TBL] [Abstract][Full Text] [Related]
20. PDEF is a negative regulator of colon cancer cell growth and migration.
Moussa O; Turner DP; Feldman RJ; Sementchenko VI; McCarragher BD; Desouki MM; Fraig M; Watson DK
J Cell Biochem; 2009 Dec; 108(6):1389-98. PubMed ID: 19830706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]